Myopathy with anti-HMGCR antibodies
Perimysium and myofiber pathology
Citation Manager Formats
Make Comment
See Comments

Article Information
- Received February 23, 2015
- Accepted in final form May 1, 2015
- First Published June 4, 2015.
Author Disclosures
- Ali Alshehri, MD,
- Rati Choksi, MS,
- Robert Bucelli, MD, PhD and
- Alan Pestronk, MD
- Ali Alshehri, MD,
NONE
NONE
NONE
NONE
NONE
NONE
NONE
NONE
NONE
NONE
NONE
NONE
NONE
NONE
NONE
NONE
NONE
NONE
NONE
NONE
NONE
- Rati Choksi, MS,
NONE
NONE
NONE
NONE
NONE
NONE
NONE
NONE
NONE
NONE
NONE
NONE
NONE
NONE
NONE
NONE
NONE
NONE
NONE
NONE
NONE
- Robert Bucelli, MD, PhD and
NONE
1) Parents of a family member I care for with Parsonage Turner syndrome, a financial gift was provided to me in hopes that it could be used towards Parsonage Turner research
NONE
NONE
NONE
NONE
NONE
NONE
NONE
NONE
NONE
NONE
NONE
NONE
NONE
NONE
NONE
NONE
NONE
NONE
NONE
- Alan Pestronk, MD
Myositis Association, scientific advisory board
NONE
NONE
NONE
(1) TS-HDS antibody 7,175,989, issued 2007; (2) GALOP antibody 6,121,004, issued 2000; (3) GM1 ganglioside antibody 6,077,681, issued 2000; (4) Sulfatide antibody 6,020,140, issued 1995
NONE
NONE
NONE
Athena, speaker honoraria 2007-2009 The Myositis Association 2014-2015
NONE
NONE
(1) Genzyme, (2) Insmed, (3) Knopp, (4) Ultragenyx, (5) ISIS, (6) Sanofi, (7) Cytokinetics, (8) GSK, (9) Biogen, (10) CSL Behring
NIH
Washington University Neuromuscular Research Fund
(1) CINRG Children's Hospital Washington DC, Investigator 2007–2009; (2) Muscular Dystrophy Association, Investigator 2007-2009
NONE
NONE
NONE
NONE
NONE
NONE
- From the Department of Neurology (A.A., R.C., R.B., A.P.) and Department of Pathology and Immunology (A.P.), Washington University School of Medicine, Saint Louis, MO.
- Correspondence to Dr. Pestronk: pestronka{at}neuro.wustl.edu
Article usage
Letters: Rapid online correspondence
REQUIREMENTS
You must ensure that your Disclosures have been updated within the previous six months. Please go to our Submission Site to add or update your Disclosure information.
Your co-authors must send a completed Publishing Agreement Form to Neurology Staff (not necessary for the lead/corresponding author as the form below will suffice) before you upload your comment.
If you are responding to a comment that was written about an article you originally authored:
You (and co-authors) do not need to fill out forms or check disclosures as author forms are still valid
and apply to letter.
Submission specifications:
- Submissions must be < 200 words with < 5 references. Reference 1 must be the article on which you are commenting.
- Submissions should not have more than 5 authors. (Exception: original author replies can include all original authors of the article)
- Submit only on articles published within 6 months of issue date.
- Do not be redundant. Read any comments already posted on the article prior to submission.
- Submitted comments are subject to editing and editor review prior to posting.
You May Also be Interested in
Dr. Nicole Sur and Dr. Mausaminben Hathidara
► Watch
Related Articles
- No related articles found.
Topics Discussed
Alert Me
Recommended articles
-
Article
Immune myopathy with large histiocyte-related myofiber necrosisAlan Pestronk, Namita Sinha, Ziad Alhumayyd et al.Neurology, March 20, 2019 -
Article
Necrosis in anti-SRP+ and anti-HMGCR+myopathiesRole of autoantibodies and complementYves Allenbach, Louiza Arouche-Delaperche, Corinna Preusse et al.Neurology, January 12, 2018 -
Article
Immune myopathies with perimysial pathologyClinical and laboratory featuresRobert C. Bucelli, Alan Pestronk et al.Neurology: Neuroimmunology & Neuroinflammation, January 18, 2018 -
Article
Clinical course and treatment of anti-HMGCR antibody–associated necrotizing autoimmune myopathySudarshini Ramanathan, Daman Langguth, Todd A. Hardy et al.Neurology - Neuroimmunology Neuroinflammation, April 02, 2015